Benzinga's Top Upgrades, Downgrades For January 3, 2020

Loading...
Loading...

Upgrades

  • For Alphabet Inc GOOGL, Canaccord Genuity upgraded the stock from Hold to Buy. In the third quarter, Alphabet showed an EPS of $10.12, compared to $13.06 from the year-ago quarter. The stock has a 52-week-high of $1368.68 and a 52-week-low of $1022.37. Alphabet's stock last closed at $1368.68 per share.
  • Oppenheimer changed the rating for Gilead Sciences Inc GILD from Perform to Outperform. Gilead Sciences earned $1.75 in the third quarter, compared to $1.84 in the year-ago quarter. The stock has a 52-week-high of $70.50 and a 52-week-low of $60.89. Gilead Sciences's stock last closed at $65.23 per share.
  • For Canada Goose Holdings Inc GOOS, TD Securities upgraded the stock from Hold to Buy. In the second quarter, Canada Goose Holdings showed an EPS of $0.43, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $59.94 and a 52-week-low of $31.67. Canada Goose Holdings's stock last closed at $35.70 per share.
  • Stephens & Co. upgraded the stock for Credit Acceptance Corp CACC from Underweight to Equal-Weight. In the third quarter, Credit Acceptance showed an EPS of $8.89, compared to $7.56 from the year-ago quarter. The stock has a 52-week-high of $509.99 and a 52-week-low of $373.06. Credit Acceptance's stock last closed at $442.77 per share.
  • Stephens & Co. upgraded the stock for Q2 Holdings Inc QTWO from Equal-Weight to Overweight. In the third quarter, Q2 Holdings showed an EPS of $0.05, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $93.63 and a 52-week-low of $46.12. Q2 Holdings's stock last closed at $82.79 per share.
  • Stephens & Co. upgraded the stock for Synchrony Financial SYF from Underweight to Equal-Weight. Synchrony Finl earned $1.22 in the third quarter, compared to $0.91 in the year-ago quarter. The stock has a 52-week-high of $38.18 and a 52-week-low of $23.12. Synchrony Finl's stock last closed at $36.20 per share.
  • UBS changed the rating for Illumina Inc ILMN from Neutral to Buy. Illumina earned $1.93 in the third quarter, compared to $1.52 in the year-ago quarter. The stock has a 52-week-high of $380.76 and a 52-week-low of $263.30. Illumina's stock last closed at $327.00 per share.
  • Guggenheim changed the rating for Incyte Corp INCY from Neutral to Buy. Incyte earned $0.82 in the third quarter, compared to $0.38 in the year-ago quarter. The stock has a 52-week-high of $96.79 and a 52-week-low of $62.03. Incyte's stock last closed at $85.97 per share.
  • For Waters Corp WAT, Bank of America upgraded the stock from Underperform to Neutral. Waters earned $2.13 in the third quarter, compared to $1.92 in the year-ago quarter. The stock has a 52-week-high of $255.21 and a 52-week-low of $174.95. Waters's stock last closed at $235.07 per share.
  • For Cintas Corp CTAS, Bank of America upgraded the stock from Neutral to Buy. In the second quarter, Cintas showed an EPS of $2.27, compared to $1.76 from the year-ago quarter. The stock has a 52-week-high of $277.85 and a 52-week-low of $164.50. Cintas's stock last closed at $270.79 per share.
  • For Karyopharm Therapeutics Inc KPTI, Bank of America upgraded the stock from Underperform to Neutral. For the third quarter, Karyopharm Therapeutics had an EPS of ($0.67), compared to year-ago quarter EPS of ($0.79). The stock has a 52-week-high of $20.00 and a 52-week-low of $3.92. Karyopharm Therapeutics's stock last closed at $18.72 per share.
  • Bank of America upgraded the stock for Teva Pharmaceutical Industries Ltd TEVA from Underperform to Buy. For the third quarter, Teva Pharmaceutical Indus had an EPS of $0.58, compared to year-ago quarter EPS of $0.68. The stock has a 52-week-high of $20.21 and a 52-week-low of $6.07. Teva Pharmaceutical Indus's stock last closed at $9.56 per share.
  • Credit Suisse upgraded the stock for Emerson Electric Co EMR from Neutral to Outperform. In the fourth quarter, Emerson Electric showed an EPS of $1.07, compared to $0.89 from the year-ago quarter. The stock has a 52-week-high of $77.51 and a 52-week-low of $55.98. Emerson Electric's stock last closed at $77.48 per share.
  • For Honeywell International Inc HON, Credit Suisse upgraded the stock from Neutral to Outperform. For the third quarter, Honeywell International had an EPS of $2.08, compared to year-ago quarter EPS of $2.03. The stock has a 52-week-high of $183.12 and a 52-week-low of $129.07. Honeywell International's stock last closed at $180.79 per share.
  • Raymond James changed the rating for Cigna Corp CI from Market Perform to Outperform. For the third quarter, Cigna had an EPS of $4.54, compared to year-ago quarter EPS of $3.84. The stock has a 52-week-high of $207.28 and a 52-week-low of $141.95. Cigna's stock last closed at $204.93 per share.
  • Goldman Sachs upgraded the stock for Canadian Solar Inc CSIQ from Neutral to Buy. In the third quarter, Canadian Solar showed an EPS of $0.66, compared to $1.09 from the year-ago quarter. The stock has a 52-week-high of $25.89 and a 52-week-low of $14.00. Canadian Solar's stock last closed at $22.52 per share.
  • Evercore ISI Group upgraded the stock for Anthem Inc ANTM from In-Line to Outperform. Anthem earned $4.87 in the third quarter, compared to $3.81 in the year-ago quarter. The stock has a 52-week-high of $317.99 and a 52-week-low of $227.16. Anthem's stock last closed at $300.82 per share.
  • Longbow Research changed the rating for Belden Inc BDC from Neutral to Buy. Belden earned $1.18 in the third quarter, compared to $1.72 in the year-ago quarter. The stock has a 52-week-high of $64.33 and a 52-week-low of $40.67. Belden's stock last closed at $55.25 per share.

 

Downgrades

  • Stephens & Co. downgraded the stock for ACI Worldwide Inc ACIW from Overweight to Equal-Weight. For the third quarter, ACI Worldwide had an EPS of $0.27, compared to year-ago quarter EPS of $0.26. The stock has a 52-week-high of $38.44 and a 52-week-low of $25.12. ACI Worldwide's stock last closed at $38.20 per share.
  • Stephens & Co. downgraded the stock for Genesee & Wyoming Inc GWR from Overweight to Equal-Weight. In the third quarter, Genesee & Wyoming showed an EPS of $1.16, compared to $1.23 from the year-ago quarter.
  • UBS downgraded the stock for USA Compression Partners LP USAC from Buy to Neutral. USA Compression Partners earned $0.02 in the third quarter, compared to ($0.07) in the year-ago quarter. The stock has a 52-week-high of $19.00 and a 52-week-low of $12.75. USA Compression Partners's stock last closed at $17.95 per share.
  • Guggenheim downgraded the stock for Puma Biotechnology Inc PBYI from Buy to Neutral. In the third quarter, Puma Biotechnology showed an EPS of ($0.44), compared to ($0.37) from the year-ago quarter. The stock has a 52-week-high of $43.90 and a 52-week-low of $6.26. Puma Biotechnology's stock last closed at $8.43 per share.
  • Jefferies downgraded the stock for Apple Inc AAPL from Buy to Hold. Apple earned $3.03 in the fourth quarter, compared to $2.91 in the year-ago quarter. The stock has a 52-week-high of $300.60 and a 52-week-low of $142.00. Apple's stock last closed at $300.35 per share.
  • Stephens & Co. downgraded the stock for Rent-A-Center Inc RCII from Equal-Weight to Underweight. In the third quarter, Rent-A-Center showed an EPS of $0.47, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $28.99 and a 52-week-low of $15.88. Rent-A-Center's stock last closed at $28.47 per share.
  • Loop Capital downgraded the stock for Apple Inc AAPL from Buy to Hold. Apple earned $3.03 in the fourth quarter, compared to $2.91 in the year-ago quarter. The stock has a 52-week-high of $300.60 and a 52-week-low of $142.00. Apple's stock last closed at $300.35 per share.
  • For Lumber Liquidators Holdings Inc LL, Loop Capital downgraded the stock from Buy to Hold. For the third quarter, Lumber Liquidators Hldgs had an EPS of $0.08, compared to year-ago quarter EPS of $0.27. The stock has a 52-week-high of $14.44 and a 52-week-low of $6.59. Lumber Liquidators Hldgs's stock last closed at $9.54 per share.
  • Bank of America changed the rating for Robert Half International Inc RHI from Buy to Neutral. For the third quarter, Robert Half International had an EPS of $1.01, compared to year-ago quarter EPS of $0.95. The stock has a 52-week-high of $69.08 and a 52-week-low of $51.90. Robert Half International's stock last closed at $63.73 per share.
  • Bank of America changed the rating for Quest Diagnostics Inc DGX from Neutral to Underperform. Quest Diagnostics earned $1.76 in the third quarter, compared to $1.68 in the year-ago quarter. The stock has a 52-week-high of $108.95 and a 52-week-low of $79.93. Quest Diagnostics's stock last closed at $105.73 per share.
  • For Mettler-Toledo International Inc MTD, Bank of America downgraded the stock from Buy to Neutral. For the third quarter, Mettler-Toledo Intl had an EPS of $5.77, compared to year-ago quarter EPS of $5.12. The stock has a 52-week-high of $873.51 and a 52-week-low of $500.74. Mettler-Toledo Intl's stock last closed at $805.14 per share.
  • Bank of America changed the rating for NewLink Genetics Corp NLNK from Neutral to Underperform. For the third quarter, NewLink Genetics had an EPS of ($0.39), compared to year-ago quarter EPS of ($0.20). The stock has a 52-week-high of $3.60 and a 52-week-low of $1.13. NewLink Genetics's stock last closed at $2.26 per share.
  • Bank of America changed the rating for Laboratory Corp of America Holdings LH from Neutral to Underperform. For the third quarter, Laboratory Corp had an EPS of $2.90, compared to year-ago quarter EPS of $2.74. The stock has a 52-week-high of $178.44 and a 52-week-low of $122.27. Laboratory Corp's stock last closed at $167.49 per share.
  • Bank of America downgraded the stock for CBRE Group Inc CBRE from Buy to Neutral. In the third quarter, CBRE Group showed an EPS of $0.79, compared to $0.79 from the year-ago quarter. The stock has a 52-week-high of $61.90 and a 52-week-low of $37.85. CBRE Group's stock last closed at $61.47 per share.
  • Bank of America changed the rating for Industrial Logistics Properties Trust ILPT from Neutral to Underperform. Industrial Logistics earned $0.44 in the third quarter, compared to $0.39 in the year-ago quarter. The stock has a 52-week-high of $23.16 and a 52-week-low of $18.03. Industrial Logistics's stock last closed at $22.12 per share.
  • Bank of America downgraded the stock for Jones Lang LaSalle Inc JLL from Buy to Underperform. For the third quarter, Jones Lang LaSalle had an EPS of $3.52, compared to year-ago quarter EPS of $3.02. The stock has a 52-week-high of $175.99 and a 52-week-low of $119.79. Jones Lang LaSalle's stock last closed at $175.29 per share.
  • Bank of America downgraded the stock for AbbVie Inc ABBV from Buy to Neutral. For the third quarter, AbbVie had an EPS of $2.33, compared to year-ago quarter EPS of $2.14. The stock has a 52-week-high of $92.30 and a 52-week-low of $62.66. AbbVie's stock last closed at $89.56 per share.
  • Mizuho downgraded the stock for American Electric Power Co Inc AEP from Buy to Neutral. In the third quarter, American Electric Power showed an EPS of $1.46, compared to $1.26 from the year-ago quarter. The stock has a 52-week-high of $96.22 and a 52-week-low of $72.25. American Electric Power's stock last closed at $93.46 per share.
  • Berenberg changed the rating for Albemarle Corp ALB from Buy to Hold. In the third quarter, Albemarle showed an EPS of $1.53, compared to $1.31 from the year-ago quarter. The stock has a 52-week-high of $93.14 and a 52-week-low of $58.63. Albemarle's stock last closed at $72.59 per share.
  • Macquarie downgraded the stock for Apple Inc AAPL from Outperform to Neutral. For the fourth quarter, Apple had an EPS of $3.03, compared to year-ago quarter EPS of $2.91. The stock has a 52-week-high of $300.60 and a 52-week-low of $142.00. Apple's stock last closed at $300.35 per share.
  • For Equity Bancshares Inc EQBK, Keefe Bruyette & Woods downgraded the stock from Outperform to Market Perform. In the third quarter, Equity Bancshares showed an EPS of $0.66, compared to $0.68 from the year-ago quarter. The stock has a 52-week-high of $35.96 and a 52-week-low of $22.75. Equity Bancshares's stock last closed at $30.13 per share.
  • Evercore ISI Group downgraded the stock for Henry Schein Inc HSIC from In-Line to Underperform. Henry Schein earned $0.90 in the third quarter, compared to $1.03 in the year-ago quarter. The stock has a 52-week-high of $72.81 and a 52-week-low of $56.58. Henry Schein's stock last closed at $67.12 per share.

 

Initiations

  • Needham initiated coverage on Waters Corp WAT with a Hold rating. The price target for Waters is set at $177.00. In the third quarter, Waters showed an EPS of $2.13, compared to $1.92 from the year-ago quarter. The stock has a 52-week-high of $255.21 and a 52-week-low of $174.95. Waters's stock last closed at $235.07 per share.
  • Deutsche Bank initiated coverage on Universal Health Services Inc UHS with a Buy rating. The price target for Universal Health Services is set at $140.00. Universal Health Services earned $1.99 in the third quarter, compared to $2.23 in the year-ago quarter. The stock has a 52-week-high of $157.79 and a 52-week-low of $114.85. Universal Health Services's stock last closed at $142.33 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on Vulcan Materials Co VMC. The price target is set at $116.00 for Vulcan Materials. For the third quarter, Vulcan Materials had an EPS of $1.68, compared to year-ago quarter EPS of $1.40. The stock has a 52-week-high of $152.49 and a 52-week-low of $95.31. Vulcan Materials's stock last closed at $142.67 per share.
  • Deutsche Bank initiated coverage on Zimmer Biomet Holdings Inc ZBH with a Hold rating. The price target for Zimmer Biomet Holdings is set at $108.00. In the third quarter, Zimmer Biomet Holdings showed an EPS of $1.77, compared to $1.63 from the year-ago quarter. The stock has a 52-week-high of $151.67 and a 52-week-low of $98.60. Zimmer Biomet Holdings's stock last closed at $149.16 per share.
  • Needham initiated coverage on Thermo Fisher Scientific Inc TMO with a Strong Buy rating. The price target for Thermo Fisher Scientific is set at $271.00. In the third quarter, Thermo Fisher Scientific showed an EPS of $2.94, compared to $2.62 from the year-ago quarter. The stock has a 52-week-high of $330.14 and a 52-week-low of $210.07. Thermo Fisher Scientific's stock last closed at $326.28 per share.
  • William Blair initiated coverage on OptimizeRx Corp OPRX with an Outperform rating. In the third quarter, OptimizeRx showed an EPS of ($0.05), compared to $0.02 from the year-ago quarter. The stock has a 52-week-high of $17.24 and a 52-week-low of $8.63. OptimizeRx's stock last closed at $9.97 per share.
  • Needham initiated coverage on PerkinElmer Inc PKI with a Hold rating. The price target for PerkinElmer is set at $79.00. In the third quarter, PerkinElmer showed an EPS of $1.06, compared to $0.90 from the year-ago quarter. The stock has a 52-week-high of $103.00 and a 52-week-low of $72.16. PerkinElmer's stock last closed at $98.89 per share.
  • Deutsche Bank initiated coverage on Stryker Corp SYK with a Buy rating. The price target for Stryker is set at $179.00. For the third quarter, Stryker had an EPS of $1.91, compared to year-ago quarter EPS of $1.69. The stock has a 52-week-high of $223.45 and a 52-week-low of $151.63. Stryker's stock last closed at $210.50 per share.
  • With a rating of Hold, Deutsche Bank initiated coverage on Tenet Healthcare Corp THC. The price target is set at $20.00 for Tenet Healthcare. Tenet Healthcare earned $0.58 in the third quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of $39.37 and a 52-week-low of $16.77. Tenet Healthcare's stock last closed at $38.33 per share.
  • With a rating of Buy, Needham initiated coverage on NeoGenomics Inc NEO. The price target is set at $14.00 for NeoGenomics. In the third quarter, NeoGenomics showed an EPS of $0.07, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $30.00 and a 52-week-low of $12.04. NeoGenomics's stock last closed at $29.05 per share.
  • Needham initiated coverage on Myriad Genetics Inc MYGN with a Strong Buy rating. The price target for Myriad Genetics is set at $36.00. In the first quarter, Myriad Genetics showed an EPS of $0.08, compared to $0.43 from the year-ago quarter. The stock has a 52-week-high of $48.40 and a 52-week-low of $20.10. Myriad Genetics's stock last closed at $27.35 per share.
  • With a rating of Buy, SunTrust Robinson Humphrey initiated coverage on Integra Lifesciences Holdings Corp IART. The price target is set at $56.00 for Integra Lifesciences. In the third quarter, Integra Lifesciences showed an EPS of $0.68, compared to $0.59 from the year-ago quarter. The stock has a 52-week-high of $65.09 and a 52-week-low of $42.14. Integra Lifesciences's stock last closed at $57.87 per share.
  • Deutsche Bank initiated coverage on Mednax Inc MD with a Hold rating. The price target for Mednax is set at $34.00. In the third quarter, Mednax showed an EPS of $0.91, compared to $0.94 from the year-ago quarter. The stock has a 52-week-high of $38.88 and a 52-week-low of $19.93. Mednax's stock last closed at $27.49 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on Medtronic PLC MDT. The price target is set at $99.00 for Medtronic. For the second quarter, Medtronic had an EPS of $1.31, compared to year-ago quarter EPS of $1.22. The stock has a 52-week-high of $115.94 and a 52-week-low of $81.66. Medtronic's stock last closed at $114.56 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on Martin Marietta Materials Inc MLM. The price target is set at $198.00 for Martin Marietta Materials. In the third quarter, Martin Marietta Materials showed an EPS of $3.96, compared to $2.85 from the year-ago quarter. The stock has a 52-week-high of $281.82 and a 52-week-low of $167.62. Martin Marietta Materials's stock last closed at $276.57 per share.
  • Deutsche Bank initiated coverage on HCA Healthcare Inc HCA with a Buy rating. The price target for HCA Healthcare is set at $140.00. HCA Healthcare earned $2.23 in the third quarter, compared to $2.16 in the year-ago quarter. The stock has a 52-week-high of $150.17 and a 52-week-low of $110.31. HCA Healthcare's stock last closed at $147.47 per share.
  • Needham initiated coverage on Danaher Corp DHR with a Buy rating. The price target for Danaher is set at $114.00. Danaher earned $1.16 in the third quarter, compared to $1.10 in the year-ago quarter. The stock has a 52-week-high of $155.24 and a 52-week-low of $96.44. Danaher's stock last closed at $155.19 per share.
  • With a rating of Neutral, Goldman Sachs initiated coverage on Cision Ltd CISN. The price target is set at $12.00 for Cision. For the third quarter, Cision had an EPS of $0.21, compared to year-ago quarter EPS of $0.20. The stock has a 52-week-high of $14.55 and a 52-week-low of $6.02. Cision's stock last closed at $9.96 per share.
  • Deutsche Bank initiated coverage on DaVita Inc DVA with a Buy rating. The price target for DaVita is set at $60.00. In the third quarter, DaVita showed an EPS of $1.53, compared to $0.56 from the year-ago quarter. The stock has a 52-week-high of $75.40 and a 52-week-low of $43.40. DaVita's stock last closed at $75.24 per share.
  • With a rating of Hold, Deutsche Bank initiated coverage on Edwards Lifesciences Corp EW. The price target is set at $164.00 for Edwards Lifesciences. Edwards Lifesciences earned $1.41 in the third quarter, compared to $1.07 in the year-ago quarter. The stock has a 52-week-high of $247.64 and a 52-week-low of $140.86. Edwards Lifesciences's stock last closed at $232.49 per share.
  • With a rating of Buy, UBS initiated coverage on Cheniere Energy Inc LNG. The price target is set at $72.00 for Cheniere Energy. For the third quarter, Cheniere Energy had an EPS of ($1.14), compared to year-ago quarter EPS of $0.26. The stock has a 52-week-high of $70.60 and a 52-week-low of $57.36. Cheniere Energy's stock last closed at $62.23 per share.
  • Needham initiated coverage on Ceridian HCM Holding Inc CDAY with a Buy rating. The price target for Ceridian HCM Holding is set at $40.00. In the third quarter, Ceridian HCM Holding showed an EPS of $0.11, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $70.04 and a 52-week-low of $33.16. Ceridian HCM Holding's stock last closed at $70.00 per share.
  • Needham initiated coverage on Bruker Corp BRKR with a Strong Buy rating. The price target for Bruker is set at $39.00. Bruker earned $0.43 in the third quarter, compared to $0.37 in the year-ago quarter. The stock has a 52-week-high of $52.23 and a 52-week-low of $28.02. Bruker's stock last closed at $51.36 per share.
  • With a rating of Neutral, UBS initiated coverage on Cheniere Energy Partners LP CQP. The price target is set at $38.00 for Cheniere Energy Partners. In the third quarter, Cheniere Energy Partners showed an EPS of $0.19, compared to $0.60 from the year-ago quarter. The stock has a 52-week-high of $49.30 and a 52-week-low of $35.25. Cheniere Energy Partners's stock last closed at $39.40 per share.
  • Needham initiated coverage on Agilent Technologies Inc A with a Buy rating. The price target for Agilent Technologies is set at $77.00. Agilent Technologies earned $0.89 in the fourth quarter, compared to $0.81 in the year-ago quarter. The stock has a 52-week-high of $86.35 and a 52-week-low of $62.00. Agilent Technologies's stock last closed at $85.92 per share.
  • With a rating of Hold, Deutsche Bank initiated coverage on American Renal Associates Holdings Inc ARA. The price target is set at $12.00 for American Renal Associates. American Renal Associates earned $0.33 in the third quarter, compared to $0.19 in the year-ago quarter. The stock has a 52-week-high of $14.11 and a 52-week-low of $5.48. American Renal Associates's stock last closed at $9.76 per share.
  • Deutsche Bank initiated coverage on Acadia Healthcare Co Inc ACHC with a Hold rating. The price target for Acadia Healthcare Co is set at $27.00. Acadia Healthcare Co earned $0.52 in the third quarter, compared to $0.53 in the year-ago quarter. The stock has a 52-week-high of $35.40 and a 52-week-low of $25.13. Acadia Healthcare Co's stock last closed at $33.15 per share.
Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsConsumer DiscretionaryHealth CareHealth Care ServicesHome Improvement RetailInitiationsMaterialsPaper Productstop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...